ABVC BioPharma, Inc.
ABVC
$0.742
-$0.1725-18.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 32.81% | 10.13% | -3.05% | 35.97% | 37.06% |
| Total Depreciation and Amortization | 6.57% | 12.50% | -6.02% | 20.17% | 32.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.07% | 91.40% | 106.87% | -34.01% | -53.40% |
| Change in Net Operating Assets | -114.60% | -107.61% | -51.37% | 26.46% | 234.14% |
| Cash from Operations | 57.44% | 1.38% | 45.59% | 42.75% | 55.43% |
| Capital Expenditure | 100.00% | -371.11% | 20.00% | 82.29% | 82.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 126.75% | 104.97% | 78.84% | 78.84% | 47.22% |
| Cash from Investing | 125.80% | 103.93% | 77.88% | 79.08% | 50.67% |
| Total Debt Issued | -71.00% | -140.58% | -141.10% | 317.89% | 281.74% |
| Total Debt Repaid | 82.09% | 100.00% | 100.00% | -- | -24,490.24% |
| Issuance of Common Stock | -14.08% | 656.80% | -73.20% | -73.20% | -87.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.71% | -- | -- | -- | -- |
| Cash from Financing | -58.45% | 30.24% | -61.60% | -2.37% | -58.01% |
| Foreign Exchange rate Adjustments | -150.80% | -215.32% | 115.14% | 103.12% | 218.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.66% | 100.02% | 30.94% | 86.95% | 65.75% |
